mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.02 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |